Full-Time

KOL Engagement Manager

Confirmed live in the last 24 hours

Penumbra Inc

Penumbra Inc

1,001-5,000 employees

Develops medical devices for vascular conditions

Biotechnology
Healthcare

Compensation Overview

$75k - $110kAnnually

+ Competitive Compensation Package + Equity Program

Junior, Mid

Company Historically Provides H1B Sponsorship

Alameda, CA, USA

Category
General Marketing
Growth & Marketing
Required Skills
Word/Pages/Docs
Tableau
Salesforce
Marketing
Data Analysis
Excel/Numbers/Sheets

You match the following Penumbra Inc's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s degree in Marketing, Business, Communications, or a related field
  • 1+ years of experience in marketing, preferably in the medical device or healthcare industry, or equivalent combination of education and experience
  • Good knowledge of MS Excel and Analytics software (Tableau, Salesforce, etc.)
  • Strong oral, written and interpersonal communication skills
  • High degree of accuracy and attention to detail
  • Proficiency with Microsoft Word, Excel, PowerPoint, and other standard office tools
  • Ability to coordinate remotely via audio/video conferencing
  • Excellent organizational, time management and prioritization skills
  • Ability to interact with team members and customers (internal and external) in a professional manner
  • Ability to set and maintain project delivery timelines with regular updates to key stakeholders
  • Must be creative, self-motivated, team-oriented, proactive, intuitive, organized, collaborative, and flexible
Responsibilities
  • Assist product marketing teams with creating, updating, and managing marketing literature, sales tools, and educational videos
  • Support the creation of marketing materials, including presentations and digital content
  • Manage marketing content, tools, literature, and presentations
  • Collaborate closely with product marketing teams to identify opportunities for new materials and messaging pull through
  • Translate complex ideas and information into clear, actionable recommendations and findings
  • Assist in the creation and management of event-related materials
  • Analyze marketing performance drivers to shape content creation
  • Develop and share key strategic insights through data analysis and visualization
  • Coordinate with internal teams and customers to ensure the timely delivery of materials
  • Maintain marketing calendars and schedules for the vascular franchise
  • Adhere to the Company’s Quality Management System (QMS) as well as domestic and global quality system regulations, standards, and procedures
  • Understand relevant security, privacy and compliance principles and adhere to the regulations, standards, and procedures that are applicable to the Company
  • Ensure other members of the department follow the QMS, regulations, standards, and procedures
  • Perform other work-related duties as assigned
Desired Qualifications
  • Analytical abilities preferred

Penumbra Inc. creates medical devices for treating neurovascular and peripheral vascular conditions, including products like the Penumbra System for stroke treatment and the Indigo System for peripheral diseases. Their devices assist healthcare professionals in hospitals and clinics across Europe and the Americas. Penumbra stands out from competitors by focusing on specialized devices and investing in research and development to meet the evolving needs of the medical community. The company's goal is to provide high-quality solutions that improve patient outcomes in vascular care.

Company Size

1,001-5,000

Company Stage

IPO

Total Funding

$116.7K

Headquarters

Alameda, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for minimally invasive procedures aligns with Penumbra's catheter technologies.
  • Expansion in emerging markets offers new growth opportunities for Penumbra.
  • Integration of AI in medical devices presents innovation opportunities for Penumbra.

What critics are saying

  • Layoffs in Immersive Healthcare may indicate financial strain or strategic shifts.
  • Resource diversion to EMBOLIZE trial could impact core product focus.
  • Regulatory challenges in Europe may affect BMX81 and BMX96 sales.

What makes Penumbra Inc unique

  • Penumbra specializes in neurovascular and peripheral vascular medical devices.
  • The company offers innovative solutions for stroke and neurovascular disease treatment.
  • Penumbra's global reach includes markets in Europe, Americas, Asia, and Australia.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Parental Leave

Paid Vacation

Paid Sick Leave

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
PR Newswire
Jan 21st, 2025
Penumbra, Inc. Schedules Fourth Quarter And Full Year 2024 Earnings Release And Conference Call For February 18, 2025

ALAMEDA, Calif., Jan. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2024 after market close on Tuesday, February 18, 2025 at 4:30 PM Eastern Time. A press release with fourth quarter and full year 2024 financial results will be issued after market close that day.Webcast & Conference Call InformationThe conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 5872954), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the completion of the call.About PenumbraPenumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity

Interventional News
Jan 10th, 2025
Interventional News' top 10 most popular stories of 2024

The Society of Interventional Radiology (SIR) Foundation, The VIVA Foundation and Penumbra, today announced the launch of the EMBOLIZE trial, a first-of-its-kind prospective, randomised controlled trial studying the effects of ovarian vein embolization (OVE) and pelvic vein embolization in reducing pain in women experiencing chronic pelvic pain due to pelvic venous disease (PeVD).

PR Newswire
Dec 30th, 2024
Penumbra, Inc. To Present At The 43Rd Annual J.P. Morgan Healthcare Conference

ALAMEDA, Calif., Dec. 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. Event:     43rd Annual J.P. Morgan Healthcare ConferenceDate:       Monday, January 13, 2025Time:      6:00pm ET/3:00pm PT

PR Newswire
Nov 20th, 2024
Penumbra, Inc. To Present At The Piper Sandler 36Th Annual Healthcare Conference

ALAMEDA, Calif., Nov. 20, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024. Event:     Piper Sandler 36th Annual Healthcare ConferenceDate:      Wednesday, December 4, 2024Time:      8:00am ET/5:00am PT. A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the event

MedTech Dive
Aug 29th, 2024
Penumbra axes virtual reality division, will lay off 71 people

Penumbra will lay off 71 people working in its Immersive Healthcare business, according to a California Worker Adjustment and Retraining Notification notice obtained by MedTech Dive.